ChemicalBook >> CAS DataBase List >>GLPG-1690
GLPG-1690
- CAS No.
- 1628260-79-6
- Chemical Name:
- GLPG-1690
- Synonyms
- ziritaxestat;GLPG11690;2-((2-ethyl-6-(4-(2-(3-hydroxyazetidin-1-yl)-2-oxoethyl)piperazin-1-yl)-8-methylimidazo[1,2-a]pyridin-3-yl)(methyl)amino)-4-(4-fluorophenyl)thiazole-5-carbonitrile;CS-2644;GLPG-1690;GLPG 1690;GLPG1690;GLPG-1690 USP/EP/BP;Ziritaxestat (GLPG-1690);GLPG-1690; GLPG 1690; GLPG1690; ZIRITAXESTAT.;2-[[2-Ethyl-6-[4-[2-(3-hydroxy-1-azetidinyl)-2-oxoethyl]-1-piperazinyl]-8-methylimidazo[1,2-a]pyridin-3-yl](methyl)amino]-4-(4-fluorophenyl)thiazole-5-carbonitrile
- CBNumber:
- CB93152899
- Molecular Formula:
- C30H33FN8O2S
- Molecular Weight:
- 588.7
- MDL Number:
- MFCD31544330
- MOL File:
- 1628260-79-6.mol
Last updated:2023-06-08 09:02:56
| Density | 1.42±0.1 g/cm3(Predicted) |
|---|---|
| storage temp. | Store at -20°C |
| solubility |
DMSO:70.84(Max Conc. mg/mL);120.32(Max Conc. mM) Ethanol:4.0(Max Conc. mg/mL);6.79(Max Conc. mM) |
| form | A crystalline solid |
| pka | 13.72±0.20(Predicted) |
| FDA UNII | I02418V13W |
SAFETY
Risk and Safety Statements
| Symbol(GHS) |  GHS07 |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Signal word | Warning | |||||||||
| Hazard statements | H302-H315-H319-H335 | |||||||||
| Precautionary statements | P261-P305+P351+P338 | |||||||||
| NFPA 704 |
|
GLPG-1690 price More Price(16)
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| Cayman Chemical | 25498 | GLPG1690 ≥98% | 1628260-79-6 | 5mg | $93 | 2024-03-01 | Buy |
| Cayman Chemical | 25498 | GLPG1690 ≥98% | 1628260-79-6 | 10mg | $166 | 2024-03-01 | Buy |
| Cayman Chemical | 25498 | GLPG1690 ≥98% | 1628260-79-6 | 25mg | $343 | 2024-03-01 | Buy |
| Cayman Chemical | 25498 | GLPG1690 ≥98% | 1628260-79-6 | 50mg | $593 | 2024-03-01 | Buy |
| TRC | G411813 | GLPG1690 | 1628260-79-6 | 25mg | $310 | 2021-12-16 | Buy |
GLPG-1690 Chemical Properties,Uses,Production
Uses
GLPG1690 is a selective autotaxin inhibitor discovered by Galapagos, with potential application in idiopathic pulmonary disease (IPF). In a Phase 1 study in healthy human volunteers, GLPG1690 demonstrated favorable safety and tolerability, as well as a strong pharmacodynamic signal implying target engagement.
GLPG-1690 Preparation Products And Raw materials
Raw materials
Preparation Products
Global( 90)Suppliers
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| ATK CHEMICAL COMPANY LIMITED | +undefined-21-51877795 | ivan@atkchemical.com | China | 32686 | 60 |
| Hangzhou FandaChem Co.,Ltd. | 008657128800458; +8615858145714 | fandachem@gmail.com | China | 9341 | 55 |
| BOC Sciences | +1-631-485-4226 | inquiry@bocsci.com | United States | 19553 | 58 |
| CONIER CHEM AND PHARMA LIMITED | +8618523575427 | sales@conier.com | China | 49391 | 58 |
| HANGZHOU CLAP TECHNOLOGY CO.,LTD | 86-571-88216897,88216896 13588875226 | sales@hzclap.com | CHINA | 6313 | 58 |
| Dideu Industries Group Limited | +86-29-89586680 +86-15129568250 | 1026@dideu.com | China | 28455 | 58 |
| Finetech Industry Limited | +86-27-87465837 +8618971612321 | info@finetechnology-ind.com | China | 9635 | 58 |
| Zhejiang J&C Biological Technology Co.,Limited | +1-2135480471 +1-2135480471 | sales@sarms4muscle.com | China | 10523 | 58 |
| InvivoChem | +1-708-310-1919 +1-13798911105 | sales@invivochem.cn | United States | 6393 | 58 |
| LEAP CHEM CO., LTD. | +86-852-30606658 | market18@leapchem.com | China | 24738 | 58 |
View Lastest Price from GLPG-1690 manufacturers
| Image | Update time | Product | Price | Min. Order | Purity | Supply Ability | Manufacturer | |
|---|---|---|---|---|---|---|---|---|
 |
2021-08-19 | GLPG-1690 USP/EP/BP
1628260-79-6
|
US $1.10 / g | 1g | 99.9% | 100 Tons min | Dideu Industries Group Limited |
-
- GLPG-1690 USP/EP/BP
1628260-79-6
- US $1.10 / g
- 99.9%
- Dideu Industries Group Limited
1628260-79-6(GLPG-1690)Related Search:
GLPG-1690
5-Thiazolecarbonitrile, 2-[[2-ethyl-6-[4-[2-(3-hydroxy-1-azetidinyl)-2-oxoethyl]-1-piperazinyl]-8-methylimidazo[1,2-a]pyridin-3-yl]methylamino]-4-(4-fluorophenyl)-
CS-2644
GLPG 1690;GLPG1690
GLPG-1690; GLPG 1690; GLPG1690; ZIRITAXESTAT.
GLPG-1690 USP/EP/BP
2-((2-ethyl-6-(4-(2-(3-hydroxyazetidin-1-yl)-2-oxoethyl)piperazin-1-yl)-8-methylimidazo[1,2-a]pyridin-3-yl)(methyl)amino)-4-(4-fluorophenyl)thiazole-5-carbonitrile
ziritaxestat
GLPG11690
Ziritaxestat (GLPG-1690)
2-[[2-Ethyl-6-[4-[2-(3-hydroxy-1-azetidinyl)-2-oxoethyl]-1-piperazinyl]-8-methylimidazo[1,2-a]pyridin-3-yl](methyl)amino]-4-(4-fluorophenyl)thiazole-5-carbonitrile
1628260-79-6
C30H33FN8O2S
APIS
API